Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome Integrity and Neurological Disease. | Int J Mol Sci | 2022 | 35456958 | PubTator, text mining | PubMed |
| Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer-An Opportunity for Targeted Therapy. | Diagnostics (Basel) | 2022 | 35453890 | PubTator, text mining | PubMed |
| Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy. | Radiat Oncol | 2022 | 35440003 | PubTator, text mining | PubMed |
| The Role of DNA Repair in Immunological Diversity: From Molecular Mechanisms to Clinical Ramifications. | Front Immunol | 2022 | 35432317 | PubTator, text mining | PubMed |
| RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p-DNA-PKcs. | Cancer Med | 2022 | 35426246 | PubTator, text mining | PubMed |
| Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis. | J Exp Med | 2022 | 35420632 | PubTator, text mining | PubMed |
| Microarray screening reveals two non-conventional SUMO-binding modules linked to DNA repair by non-homologous end-joining. | Nucleic Acids Res | 2022 | 35420136 | PubTator, text mining | PubMed |
| Germline Variants in Cancer Genes from Young Breast Cancer Mexican Patients. | Cancers (Basel) | 2022 | 35406420 | PubTator, text mining | PubMed |
| Improved loss-of-function CRISPR-Cas9 genome editing in human cells concomitant with inhibition of TGF-β signaling. | Mol Ther Nucleic Acids | 2022 | 35402072 | PubTator, text mining | PubMed |
| SENP3-mediated TIP60 deSUMOylation is required for DNA-PKcs activity and DNA damage repair. | MedComm (2020) | 2022 | 35356800 | PubTator, text mining | PubMed |
| TBX20 inhibits colorectal cancer tumorigenesis by impairing NHEJ-mediated DNA repair. | Cancer Sci | 2022 | 35348274 | PubTator, text mining | PubMed |
| Combining Carbon-Ion Irradiation and PARP Inhibitor, Olaparib Efficiently Kills BRCA1-Mutated Triple-Negative Breast Cancer Cells. | Breast Cancer (Auckl) | 2022 | 35340889 | PubTator, text mining | PubMed |
| Theoretical Studies of Cyanophycin Dipeptides as Inhibitors of Tyrosinases. | Int J Mol Sci | 2022 | 35328756 | PubTator, text mining | PubMed |
| Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy. | Int J Mol Sci | 2022 | 35328658 | PubTator, text mining | PubMed |
| Interactions between miRNAs and Double-Strand Breaks DNA Repair Genes, Pursuing a Fine-Tuning of Repair. | Int J Mol Sci | 2022 | 35328651 | PubTator, text mining | PubMed |
| Cell Signaling Pathways That Promote Radioresistance of Cancer Cells. | Diagnostics (Basel) | 2022 | 35328212 | PubTator, text mining | PubMed |
| PARP Inhibitors Resistance: Mechanisms and Perspectives. | Cancers (Basel) | 2022 | 35326571 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response Pathway as a Novel Therapeutic Strategy in Colorectal Cancer. | Cancers (Basel) | 2022 | 35326540 | PubTator, text mining | PubMed |
| Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions. | Cells | 2022 | 35326449 | PubTator, text mining | PubMed |
| Association of XRCC3, XRCC4, BAX, and BCL-2 Polymorphisms with the Risk of Breast Cancer. | Int J Breast Cancer | 2022 | 35320970 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=30